Active antitumor immunity elicited by vaccine based on recombinant form of epidermal growth factor receptor.
Hu B, Wei Y, Tian L, Zhao X, Lu Y, Wu Y, Yao B, Liu J, Niu T, Wen Y, He Q, Su J, Huang M, Lou Y, Luo Y, Kan B.
Hu B, et al.
J Immunother. 2005 May-Jun;28(3):236-44. doi: 10.1097/01.cji.0000161394.11831.3f.
J Immunother. 2005.
PMID: 15838380